PhD
-
Highlights from the Program Chair: Tuesday, April 13
Program Committee Chair Charles Swanton, MBPhD, FAACR, shares some of his selections from the day’s sessions to help plan your Annual Meeting experience.
-
New Drugs on the Horizon sessions offer first disclosures of novel agents
Investigators in three related sessions shared details about 12 small molecules and biologics in or about to be tested in phase I clinical trials.
-
Panel explores ongoing controversy of p-values in scientific research
(From left) Steven Goodman, MD, MHS, PhD, Mi-Ok Kim, PhD, and Motomi Mori, PhD, discussed current schools of thought regarding their use or misuse in studies.
-
Opening Plenary brings together researchers leading the way to the latest clinical breakthroughs
“This program really encapsulates the bench-to-bedside aspects of cancer research and clinical treatment,” said Charles Swanton, MBPhD, FAACR, who will chair this #AACR21 session.
-
Robust daily plenary lineup features latest developments across all of cancer research
Session chairs (clockwise, from top left) Nina Bhardwaj, MD, PhD, Christina Curtis, PhD, MSc, Sheila Stewart, PhD, and Zuzana Storchová, PhD, preview their upcoming plenaries.